P53-deficient mice are extremely susceptible to radiation-induced tumorigenesis

Nature Genetics

Volumn 8, Issue 1, 1994, Pages 66-69

  Kemp, Christopher J ^a   Wheldon, Tom ^b   Balmain, Allan ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b Garscube Estate ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; SARCOMA;

ANIMAL; GENES, P53; HETEROZYGOTE; LYMPHOMA; MICE; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS, RADIATION-INDUCED; SARCOMA, EXPERIMENTAL; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

ANIMALIA;

EID: 0028168643     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0994-66     Document Type: Article

References (28)

1. UNSCEAR United Nations Scientific Committee on the Effects of Atomic Radiation. (United Nations, New York, 1988).
2. Breimer, L.H. Ionizing radiation-induced mutagenesis. Brit. J. Cancer 57, 6-18 (1988).
3. Keurbitz, S.J., Plunkett, B.S., Walsh, W.V. & Kastan, M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. natn. Acad. Sci. U.S.A. 89, 7491-7495 (1992).
4. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature362, 847-849 (1993).
5. Clarke, A.R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852 (1993).
6. Merritt, A.J. et al. The role of spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice.Cancer Res. 54, 614-617 (1994).
7. Lotem, J. & Sachs, L. Hematopoeitic cells from mice deficient in wild type p53 are more resistant to induction of apoptosis by some agents. Blood82, 1092-1096 (1993).
8. Lane, D.P. p53, guardian of the genome. Nature 358, 15-16 (1992).
9. Harvey, M. et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457-2467 (1993).
10. Livingstone, L.R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935 (1992).
11. Lee, J.M. & Bernstein, A. p53 mutations increase resistance to ionizing radiation. Proc. natn. Acad. Sci. U.S.A. 90, 5742-5746 (1993).
12. Slichenmyer, W.J., Nelson, W.G., Slebos, R.J. & Kastan, M.B. Loss of p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53, 4164-4168 (1993).
13. Kemp, C.J., Donehower, L.A., Bradley, A. & Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822 (1993).
14. Nelson, W.G. & Kastan, M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.Molec. cell. Biol. 14, 1815-1823 (1994).
15. Harvey, M., McArthur, M.J., Montgomery, C.A. Jr., Butel, J.S., Bradley, A. & Donehower, L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5, 225-229 (1993).
16. Purdie, C.A. et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene. 9, 603-609 (1994).
17. Jacks, T. et al. Tumour spectrum analysis in p53-mutant mice. Current Biol. 4, 1-7 (1994).
18. Searle, A.G. The biological basis of risk assesment 123-137 (Taylor and Francis, New York, 1989).
19. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
20. Kennedy, A.R., Fox, M., Murphy, G. & Little, J.B. Relationship between x-ray exposure and malignant transformation of C3H 10 T1/2 cells. Proc. natn. Acad. Sci. U.S.A. 77, 7262-7266 (1980).
21. Yi, C.H., Yandell, D.W. & Little, J.B. Evidence for coincident mutations in human lymphoblast clones selected for functional loss of a thymidine kinase gene. Molec. Carcinog. 5, 270-277 (1992).
22. Kadhim, M.A. et al. Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 355, 738-740 (1992).
23. Marder, B.A. & Morgan, W.F. Delayed chromosomal instability induced by DNA damage. Molec. cell. Biol. 13, 6667-6677 (1993).
24. Kemp, C.J., Fee, F. & Balmain, A. Allelotype analysis of mouse skin tumours using polymorphic microsatellites: sequencial genetic alterations on chromosomes 6, 7 and 11. Cancer Res. 53, 6022-6027 (1993).
25. Wiseman, R.W., Cochran, C., Dietrich, W., Lander, E.S. & Soderkvist, P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heteroygosity in regions homologous to human tumor-suppressor genes. Proc. natn. Acad. Sci. U.S.A. 91, 3759-3763 (1994).
26. Srivastava, S., Zou, Z.Q., Pirolla, K., Blattner, W. & Chang, E.H. Germ line transmission of a mutated p53 gene in a family with Li-Fraumeni syndrome. Nature 348, 747-749 (1990).
27. Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250, 1233-1238 (1990).
28. Li, F.P. et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 48, 5358-5362 (1988).